Wellcome Trust
FoundationLondon · Seed–Late Stage
What they invest in
from 1 of 1 portfolio companiesDeep Tech ×1Healthtech ×1Medical Devices ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro pathCorInnova develops a minimally invasive, non-blood contacting cardiac assist device designed to treat acute heart failure patients who cannot use existing solutions.
Deep TechHealthtechMedical DevicesHouston, US
John Criscione(Director)Dennis Robins(Director)Boris Leschinsky(Executive Officer)Clarice Motter(Executive Officer)Keith Svagerko(Executive Officer)William Altman(Executive Officer, Director)
Principals & officers · per Companies House
what is this? ⓘSecretary · since 2016
Director · Australian · since 2021
Director · British · since 2019
Director · Chinese · since 2021
Director · British · since 2023
Director · British · since 2023
Director · United Kingdom · since 2018
Director · British · since 2019
Director · Senegalese · since 2020
Director · British · since 2021
Frequently asked questions
- What stage does Wellcome Trust invest at?
- Wellcome Trust invests at the Seed, Series B, Series C, Growth, Late Stage stages.
- What sectors does Wellcome Trust focus on?
- Wellcome Trust focuses on Biotech, Healthtech, IoT, Medical Devices.
- Where is Wellcome Trust located?
- Wellcome Trust is headquartered in London, GB.
Similar investors
SBCVC (SoftBank China Venture Capital) is a venture capital and private equity fund management firm founded in 2000, focused on investing in high-growth, high-tech companies in Greater China.
LIFTT is a venture capital holding company focused on deep tech technologies, using an operational, multi-vertical approach aimed at generating impact. It works to transform scientific research into high-impact companies, accelerating the path from lab to market.
AddVentures is the corporate venture capital arm of SCG, one of the largest industrial conglomerates in Southeast Asia. It engages with tech startups worldwide through partnerships and investments, leveraging SCG's network and resources across the region.
Olive Tree Capital invests in technology and life sciences companies, backing entrepreneurs across healthcare, fintech, enterprise, AI/ML, and frontier technology sectors.
Oxford Investment Consultants (OIC) backs founders commercialising scientific research from Oxford University and other leading UK research institutions, managing the Oxford Technology and Innovations EIS Fund (OTIF).